{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:13:19Z","timestamp":1791148399955,"version":"4.1.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.1093\/jac\/44.3.397","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T18:24:55Z","timestamp":1027707895000},"page":"397-401","source":"Crossref","is-referenced-by-count":66,"title":["In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole"],"prefix":"10.1093","volume":"44","author":[{"given":"A. J.","family":"Carrillo-Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Quind\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T.","family":"Ruesga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. del","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"Cossum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. L.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[1999,9]]},"reference":[{"key":"key\n\t\t\t\t20170411034151_R1","unstructured":"1.Wallace, T. L. & Lopez-Berestein, G. (1998) Nystatin and liposomal nystatin. In Antimicrobial Therapy and Vaccines (Yu, V. L., Merigan, T. C., Barriere, S. & White, N. J., Eds), pp. 1185\u201391. Williams & Wilkins, Baltimore, MD."},{"key":"key\n\t\t\t\t20170411034151_R2","unstructured":"2.Gordon, L. E. (1995). Nystatin therapy in experimental coccichomycosis. American Review of Tuberculosis72, 67\u201370."},{"key":"key\n\t\t\t\t20170411034151_R3","doi-asserted-by":"crossref","unstructured":"3.Wallace, T. L., Paetznick, V., Cossum, P. A., L\u00f3pez-Berestein, G., Rex, J. H. & Anaissie, E. (1997). Activity of liposomal nystatin against disseminated Aspergillus fumigatus in neutropenic mice. Antimicrobial Agents and Chemotherapy41, 2238\u201343.","DOI":"10.1128\/AAC.41.10.2238"},{"key":"key\n\t\t\t\t20170411034151_R4","doi-asserted-by":"crossref","unstructured":"4.L\u00f3pez-Berestein, G., Fainstein, V., Hopfer, R. L., Mehta, K., Sullivan, M. P., Keating, M. et al. (1985). Liposomal amphotericin-B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. Journal of Infectious Diseases151, 704\u201310.","DOI":"10.1093\/infdis\/151.4.704"},{"key":"key\n\t\t\t\t20170411034151_R5","unstructured":"5.Gonzalez, C. E., Giri, N., Shetty, D., Klighys, K., Love, W., Sein, T. et al. (1996). Efficacy of a lipid formulation of nystatin against invasive pulmonary Aspergillosis. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA. Abstract B54. p. 31. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411034151_R6","doi-asserted-by":"crossref","unstructured":"6.Boutati, E., Maltezou, H. C., L\u00f3pez-Berestein, G., Vartivarian, S. E. & Anaissie, E. J. (1995) Phase I study of maximum tolerated dose of intravenous liposomal nystatin for the treatment of refractory febrile neutropenia (RFN) in patients with haematological malignancies. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Washington, DC.","DOI":"10.1080\/02681219580000331"},{"key":"key\n\t\t\t\t20170411034151_R7","unstructured":"7.Roston, K., Baird, I., Graham, D. R. & Jauregui, L. (1998) Treatment of refractory candidemia in non-neutropenic patients with liposomal nystatin (NYOTRAN\u2122). In Program and Abstracts of the Thirty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Abstract, p. 31. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411034151_R8","unstructured":"8.Cossum, P. A., Wyse, J., Simmons, V., Wallace, T. L. & Rios, A (1996). Pharmacokinetics of NYOTRAN\u2122 (liposomal nystatin) in human patients. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA. Abstract A88. p. 17. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411034151_R9","unstructured":"9.National Committee for Clinical Laboratory Standards. (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: M27-A. NCCLS, Villanova, PA."},{"key":"key\n\t\t\t\t20170411034151_R10","doi-asserted-by":"crossref","unstructured":"10.Anaissie, E., Paetznick, V., Proffit, R., Adler-Moore, J. & Bodey, G. P. (1991). Comparison of the in-vitro antifungal activity of free and liposome-encapsulated amphotericin B. European Journal of Clinical Microbiology and Infectious Disease10, 665\u20138.","DOI":"10.1007\/BF01975823"},{"key":"key\n\t\t\t\t20170411034151_R11","doi-asserted-by":"crossref","unstructured":"11.Johnson, E. M., Ojwang, J. O., Szekely, A., Wallace, T. L. & Warnock, D. W. (1998) Comparison of in-vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations. Antimicrobial Agents and Chemotherapy42, 1412\u2013 6.","DOI":"10.1128\/AAC.42.6.1412"},{"key":"key\n\t\t\t\t20170411034151_R12","unstructured":"12.Wallace, T. L. & Lopez-Berenstein, G. (1998). Nystatin and liposomal nystatin. In Antimicrobial Chemotherapy and Vaccines (Yu, V. L., Merigan, T. C., Barriere, S. & White, N. J., Eds), pp. 1185\u201391. Williams & Wilkins, Baltimore, MD."}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/44\/3\/397\/13056853\/JAC443397.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T03:24:11Z","timestamp":1583292251000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/44.3.397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":12,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1999,9]]},"published-print":{"date-parts":[[1999,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/44.3.397","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}